A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

From Aug. 1 to the end of the year, Medicaid beneficiaries received 33,035 claims for GLP-1 drugs for weight loss, a number ...

The weight loss drug semaglutide ... She stopped using semaglutide and gained 26 pounds Rice started taking weekly injections of semaglutide in May 2022. After she achieved her goal of losing ...

Ozempic (semaglutide ... weight loss plans. If your healthcare professional deems it appropriate, they can prescribe Ozempic for you to pick up at a pharmacy of your choice, often on the same day ...

Semaglutide (known by its brandname Ozempic) has gained widespread attention for its weight loss benefits ... created automated insulin pump. After this intervention, participants took a two ...

The first study to assess how weight-loss drugs ... active ingredient, semaglutide, in different doses, and mimic the hormone glucagon-like peptide-1. Released by the gut after eating, GLP-1 ...